Table 2.

Structural changes in relation to log₂(cholesterol remnants) and log₂(triglyceride)

	log2 (cholesterol remnants)				log2 (triglyceride)
	Univariable		Multivariable		Univariable		Multivariable
	β-coefficient(std error)	P value	β-coefficient (std error)	P value	β-coefficient (std error)	P value	β-coefficient (std error)	P value
All patients
Left ventricular mass index (g/m2.7)	0.6 (0.5)	0.27	−0.5 (0.5)	0.36	1.1 (0.5)	0.03	−0.1 (0.5)	0.81
Interventricular septum diameter (mm)	0.21 (0.08)	0.01	0.01 (0.08)	0.90	0.26 (0.08)	<0.001	0.04 (0.07)	0.58
Left ventricular internal diameter (mm)	−0.21 (0.29)	0.47	−0.47 (0.30)	0.11	−0.04 (0.26)	0.89	−0.37 (0.28)	0.18
Posterior wall diameter (mm)	0.16 (0.07)	0.03	0.01 (0.07)	0.90	0.25 (0.07)	<0.001	0.07 (0.06)	0.28
Left atrial end systolic volume index (ml/m2)	−1.61 (0.39)	<0.001	−1.41 (0.41)	0.001	−1.29 (0.35)	<0.001	−1.19 (0.37)	0.002
In patients receiving statin therapy
Left ventricular mass index (g/m2.7)	0.7 (0.6)	0.24	−0.3 (0.6)	0.56	1.1 (0.5)	0.04	−0.1 (0.5)	0.86
Interventricular septum diameter (mm)	0.22 (0.09)	0.02	0.04 (0.09)	0.67	0.29 (0.09)	<0.001	0.08 (0.08)	0.35
End diastolic internal diameter (mm)	−0.30 (0.33)	0.36	−0.58 (0.34)	0.08	−0.17 (0.30)	0.57	−0.53 (0.31)	0.09
Posterior wall diameter (mm)	0.17 (0.08)	0.04	0.04 (0.08)	0.62	0.26 (0.07)	<0.001	0.10 (0.07)	0.17
Left atrial end systolic volume index (ml/m2)	−1.73 (0.45)	<0.001	−1.47 (0.47)	0.002	−1.44 (0.40)	<0.001	−1.33 (0.43)	0.002

Multivariable model adjusted for age, sex, hemoglobin A_1c, body mass index, systolic blood pressure and albuminuria

Italic text indicates P < 0.05